The histone deacetylase inhibitor, PXD101, potentiates bortezomib-induced anti-multiple myeloma effect by induction of oxidative stress and DNA damage.

Source:http://linkedlifedata.com/resource/pubmed/id/17910628

Download in:

View as

General Info

PMID
17910628